Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

Clinical trial NCT00789854 · COMPLETED

Trial details

NCT number: NCT00789854
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Treatment Resistant Depression

Start date: 2008-11-01
Primary completion: 2009-08-01
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.